# [Metabolite Class] Analysis - Implementation Plan

## 1. Executive Summary

[2-3 paragraphs covering:]
- Project scope and objectives
- Laboratory readiness assessment with approved gap solutions
- Total timeline estimate
- Total cost summary

---

## 2. Sample Reception & Storage

**Current Laboratory Capabilities:**
- [List existing sample handling capabilities]

**Project Requirements:**
- Sample type: [Type]
- Sample quantity: [Number]
- Storage conditions: -80°C
- Chain of custody procedures
- Aliquoting strategy

---

## 3. Chromatography System Setup

**Equipment:**
- LC system: [Current equipment]
- Column: [Approved column selection]

**Method Parameters:**
- Mobile phase A: [Composition]
- Mobile phase B: [Composition]
- Gradient: [Time/composition profile]
- Flow rate: [Rate]
- Column temperature: [Temp]
- Injection volume: [Volume]
- Runtime: [Time]

**Optimization Plan:**
- Week 1: Column conditioning, gradient screening
- Week 2-3: Fine-tune separation, optimize sensitivity

---

## 4. Sample Preparation Workflow

**Protocol: [Method Name]**

Step 1: [Action]
- [Details]
- [Expected outcome]

Step 2: [Action]
- [Details]
- [Expected outcome]

[Continue for all steps]

**Quality Control Checkpoints:**
- [Checkpoint 1]
- [Checkpoint 2]

---

## 5. Internal Standards Strategy

**Selected ISTD:** [User's approved choice]
- Supplier: [Name]
- Cost: $[Amount]
- Concentration: [Conc]

**Addition Protocol:**
- Add ISTD pre-extraction
- [Volume] to [sample amount]
- Final concentration: [Conc]

**Quantification:**
- Peak area ratio: (Analyte area) / (ISTD area)
- Normalizes extraction efficiency, matrix effects, instrument variability

---

## 6. Mass Spectrometry Detection

**Instrument:** [MS instrument]

**Source Parameters:**
- Ionization mode: [Positive/Negative ESI]
- Spray voltage: [Voltage]
- Capillary temperature: [Temp]
- Sheath gas: [Flow]
- Aux gas: [Flow]

**MRM Transitions:**

| Metabolite | Precursor (m/z) | Product (m/z) | Collision Energy (eV) | Retention Time (min) |
|------------|-----------------|---------------|----------------------|----------------------|
| [Name]     | [Value]         | [Value]       | [Value]              | [Value]              |

**Optimization Strategy:**
- Infusion optimization for source parameters
- Collision energy optimization for each transition
- Scheduled MRM for increased sensitivity

---

## 7. Quality Control Framework

**QC Sample Types:**

1. **Pooled QC (Type A)**
   - Purpose: Monitor system performance
   - Frequency: Every 10-15 samples
   - Acceptance: Peak area CV <30% for metabolites, <20% for ISTD

2. **Method Blank (Type B)**
   - Purpose: Detect contamination
   - Frequency: 2-3 per batch
   - Acceptance: No peaks >20% of LLOQ

3. **Matrix Blank (Type C)**
   - Purpose: Assess selectivity
   - Frequency: 1-2 per batch
   - Acceptance: No interfering peaks

4. **Calibration Standards (Type D)**
   - Purpose: Quantification curve
   - Frequency: Every batch (duplicate/triplicate)
   - Acceptance: R² ≥0.99, accuracy 85-115%

5. **QC Standards (Type E)**
   - Purpose: Validate accuracy/precision
   - Frequency: Beginning, middle, end (triplicate each)
   - Acceptance: Accuracy 85-115%, CV ≤15%

---

## 8. Method Validation

**Parameters to Validate:**

- **Selectivity**: No interferences >20% LLOQ
- **Sensitivity (LLOQ)**: S/N ≥5:1, accuracy 80-120%, CV ≤20%
- **Accuracy**: 85-115% (80-120% at LLOQ)
- **Precision**: Within-run and between-run CV ≤15% (≤20% at LLOQ)
- **Linearity**: R² ≥0.99, 6 of 8 calibrators pass
- **Matrix Effects**: Test 6+ lots, target 85-115%
- **Recovery**: 50-120% acceptable, CV <15%
- **Stability**: Freeze-thaw (3 cycles), bench-top, long-term, autosampler

**Acceptance Criteria:** FDA Bioanalytical Method Validation Guidelines (2018)

**Timeline:** 2-4 weeks

---

## 9. Sample Throughput & Batch Design

**Batch Size:** [20-50 samples typical]

**Batch Structure:**
- System suitability samples (beginning)
- Calibration curve (duplicate)
- QC standards (low, mid, high) - triplicate at start
- Study samples (randomized)
- Pooled QC every 10-15 samples
- QC standards (triplicate) at middle
- Study samples continue
- QC standards (triplicate) at end
- Calibration curve (duplicate)

**Randomization:** Block randomization to distribute groups evenly

**Throughput:** 30-50 samples/day including QC

---

## 10. Data Processing & Analysis

**Software Workflow:**
1. Peak integration: [Software name]
2. Manual review of all peaks
3. Quantification using calibration curves
4. QC evaluation
5. Data export

**Statistical Analysis:**
- Normalization strategy
- Group comparisons (t-test, ANOVA)
- Multivariate analysis (PCA, PLS-DA)
- Pathway analysis (if applicable)

---

## 11. Deliverables & Reporting

**Data Files:**
- Raw data files (.raw or equivalent)
- Processed data tables (Excel/CSV)
- Calibration curves and QC charts
- Method validation report

**Final Report:**
- Executive summary
- Methods section (sample prep, LC-MS parameters, validation)
- Results section (quantification tables, statistical analysis)
- QC performance summary
- Figures (heatmaps, PCA plots, volcano plots)
- Discussion and conclusions

---

## 12. Timeline & Milestones

**Phase 1: Procurement** (1-3 weeks)
- Order approved consumables
- Receive and log all materials
- Milestone: All materials on hand

**Phase 2: Method Development** (2-4 weeks)
- Install and condition column
- Optimize chromatography and MS
- Establish performance metrics
- Milestone: Method meets sensitivity/separation targets

**Phase 3: Method Validation** (2-4 weeks)
- Execute validation experiments
- Document all parameters
- Milestone: Method passes FDA criteria

**Phase 4: Sample Analysis** ([Variable based on sample count])
- Extract samples in batches
- Analyze on LC-MS
- Real-time QC monitoring
- Milestone: All samples analyzed with passing QC

**Phase 5: Data Processing & Reporting** (1-3 weeks)
- Process all data
- Statistical analysis
- Generate report
- Client review and revisions
- Milestone: Final report delivered

**Total Timeline:** [X-Y weeks from approval to delivery]

---

## 13. Cost Structure

**One-Time Setup Costs:**
- [Item 1]: $[Cost]
- [Item 2]: $[Cost]
- [Item 3]: $[Cost]
- **Subtotal:** $[Total]

**Per-Sample Costs:**
- Consumables: $[Cost]/sample
- Extraction solvents: $[Cost]/sample
- Internal standard: $[Cost]/sample
- LC-MS analysis: $[Cost]/sample
- Data processing: $[Cost]/sample
- **Subtotal:** $[Cost]/sample

**Total Project Cost:**
- Setup: $[Amount]
- Sample analysis ([N] samples × $[cost]): $[Amount]
- **Grand Total:** $[Amount]

---

## 14. Risk Assessment & Mitigation

**Risk 1: Supplier Delays**
- Probability: Medium | Impact: Medium
- Mitigation: Order immediately, identify alternative suppliers
- Timeline buffer: +1 week

**Risk 2: Method Development Challenges**
- Probability: Medium | Impact: Medium
- Mitigation: Literature review, manufacturer support
- Timeline buffer: +1 week

**Risk 3: Matrix Effects Beyond Acceptable Range**
- Probability: Low-Medium | Impact: Medium
- Mitigation: Use isotope-labeled ISTD, sample dilution if needed
- Timeline impact: +1 week for optimization

**Risk 4: Poor Chromatographic Separation**
- Probability: Low | Impact: High
- Mitigation: Literature-recommended columns
- Contingency: Test alternative columns
- Timeline impact: +2-3 weeks if changes needed

**Risk 5: Instrument Failure**
- Probability: Low | Impact: High
- Mitigation: Preventive maintenance, service contracts
- Contingency: Backup instrument or external lab
- Timeline impact: +1-4 weeks

**Risk 6: Sample Degradation**
- Probability: Low | Impact: High
- Mitigation: Proper storage (-80°C), temperature monitoring
- Contingency: Re-collection if possible

**Risk 7: QC Failures**
- Probability: Low-Medium | Impact: Medium
- Mitigation: Robust QC framework, real-time monitoring
- Contingency: Troubleshoot and re-analyze
- Timeline impact: +1-2 weeks

**Risk 8: Budget Overruns**
- Probability: Low | Impact: Medium
- Mitigation: Detailed estimates, contingency budget
- Contingency: Phase analysis, prioritize samples

---

## 15. Success Criteria

**Method Development Success:**
- All target metabolites detected (S/N ≥10:1)
- Chromatographic resolution ≥1.5 for critical pairs
- Peak symmetry <2.0
- Retention time precision <2% RSD
- Run time ≤20 minutes

**Validation Success:**
- Selectivity: No interferences >20% LLOQ
- Accuracy: 85-115% (80-120% at LLOQ)
- Precision: CV ≤15% (≤20% at LLOQ)
- Linearity: R² ≥0.99, ≥6/8 calibrators pass
- Matrix effects: 85-115% or consistent
- All stability parameters: 85-115%

**Analysis Success:**
- ≥90% of samples analyzed successfully
- All QC acceptance criteria met
- No batch failures
- Complete data package delivered on time

**Client Satisfaction:**
- Results meet or exceed expectations
- Clear, comprehensive reporting
- Responsive communication
- Timeline and budget adherence

---

## 16. Next Steps & Approval

**Immediate Actions Required:**
1. Approve this implementation plan
2. Authorize purchase orders for:
   - [Item 1]: $[Cost]
   - [Item 2]: $[Cost]
   - [Item 3]: $[Cost]
3. Confirm sample availability and shipping timeline
4. Designate project point of contact

**Approval Sign-Off:**

Client Name: ___________________________

Signature: _____________________________

Date: __________________________________

**Questions or Modifications:**
[Space for client feedback]

---

**Once approved, we will begin Phase 1 (Procurement) immediately.**
**Estimated project completion: [X-Y weeks from today]**
**Next update: [Timeline for progress report]**
